Live tape
Top 8, mentions 7d11,159TSLA2,318 mentions▲ +0.05SPCX1,636 mentions▲ +0.07GOOGL1,570 mentions▲ +0.04CRWV1,436 mentions▲ +0.03NVDA1,214 mentions▲ +0.07QQQ1,179 mentions▲ +0.05NBIS931 mentions▲ +0.06META875 mentions▲ +0.05

Equity · Healthcare

EW

NYSE

Edwards Lifesciences (EW)

$87 +0.45% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 19, 2026

Reddit mentioned EW 11 times in the 30 days to 20 October 2026, across 5 of the communities we track. All of them were scored for sentiment: 64% read bullish, 18% bearish and 18% neither. Reddit data updated 20 October 2026.

Price · Chart
63 sessions
$95 $80 22 Jul 19 Oct

The line runs $84.36 on 22 July through $87 on 19 October, on a scale from $80 to $95. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 22 Jul – 19 Oct 2026
Market cap $50.1B
P/E (TTM) 50.0
52-week range $72.01 – $95.17
Avg volume 222.3K
Mentions · 30d 11
Net sentiment +0.03

as of Oct 19, 2026

Edwards Lifesciences (EW) · crowd attention × price

Share ↗
Post on X Share on Reddit Share on LinkedIn
11 mentions

Day17 Oct 2026

MENTIONS10–2 / day
PRICE$86.61 · closedMARKET CLOSED · held
EW over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day012usd$84$86$88$9021 Sep28 Sep6 Oct13 Oct20 Oct
EW over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.21 Sep6 Oct20 Oct
The Distributed Sentinel 20 Oct 2026

EW's busiest day for Reddit mentions was also its highest close of the window — 1 mentions and $88.81 on 22 September

This chart in words

The chart plots daily Reddit mentions of EW over the 30 days to 20 October 2026: 11 in total, busiest on 22 September with 1, and 1 on the last day counted. Across this window the close ran between $84.25 on 8 October and $88.81 on 22 September. The line is the daily close over the same window: $88.33 on 21 September, $87 on 19 October. Of those days, 21 were trading sessions and the other 9 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Edwards Lifesciences (EW) on Reddit · 30d

n = 11 scored · Method

In the 30 days to 21 Oct 2026, Edwards Lifesciences drew 11 Reddit mentions in the finance subreddits we track, 11 of them scored for sentiment.

EW

64% bullish

Overall market sentiment

54% bullish

EW reads 10 points more bullish than overall market sentiment. Same measure; same 30-day window.

Where EW is discussed

(30d)
r/wallstreetbets 67% 8 +0.00
r/etfs 8% 1 +0.09
r/options 8% 1 +0.00
r/stocks 8% 1 +0.17
r/asx 8% 1 +0.02

Moves with EW

co-mention r · 31 obs

Tickers whose daily Reddit volume rose and fell with EW's. Co-discussion, not price.

VINE +0.63 ZROZ +0.57 JANESTREET.PRV +0.54 DADS +0.54 INN +0.53 DOVISH +0.53

How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations) · Method

Edwards Lifesciences (EW) insider trades

SEC Form 4 · last 90 days · newest reported trade 8 Oct 2026

In the 90 days to 21 Oct 2026, Edwards Lifesciences insiders reported 10 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 22 Feb 2026, show no open-market purchase.

Open-market buys 0
Open-market sells 10
Net sold $4.54M
Non-trade filings 10
Date Insider Type Shares Value
08 Oct 2026 Lippis Daniel J. CVP, TAVR Sell 619 $53K
11 Sep 2026 Lippis Daniel J. CVP, TAVR Sell 619 $54K
31 Aug 2026 Dahl Andrew M. SVP, Corporate Controller Sell 544 $50K
28 Aug 2026 Bruls Annette CVP, EMEACLA Sell 2,644 $238K
26 Aug 2026 Chopra Daveen CVP, TMTT, Surgical & IHFM Sell 31,800 $2.89M
26 Aug 2026 Markowitz Wayne CVP, JAPAC Sell 1,240 $113K
11 Aug 2026 Lippis Daniel J. CVP, TAVR Sell 619 $57K
30 Jul 2026 Markowitz Wayne CVP, JAPAC Sell 146 $13K
28 Jul 2026 Markowitz Wayne CVP, JAPAC Sell 9,628 $819K
27 Jul 2026 Zovighian Bernard J CEO Sell 2,921 $245K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
08 Oct 2026 Lippis Daniel J. CVP, TAVR Option exercise 619 $45K
14 Sep 2026 Markowitz Wayne CVP, JAPAC Tax withheld 568 $48K
13 Sep 2026 Dahl Andrew M. SVP, Corporate Controller Tax withheld 253 $21K
11 Sep 2026 Markowitz Wayne CVP, JAPAC Tax withheld 355 $31K
11 Sep 2026 Chopra Daveen CVP, TMTT, Surgical & IHFM Tax withheld 398 $35K
11 Sep 2026 Lippis Daniel J. CVP, TAVR Option exercise 619 $45K
26 Aug 2026 Chopra Daveen CVP, TMTT, Surgical & IHFM Option exercise 31,800 $2.31M
11 Aug 2026 Lippis Daniel J. CVP, TAVR Option exercise 619 $45K
28 Jul 2026 Markowitz Wayne CVP, JAPAC Option exercise 9,628 $713K
27 Jul 2026 Zovighian Bernard J CEO Gift 639

Edwards Lifesciences (EW) reported financials

SEC EDGAR XBRL SEC EDGAR

Edwards Lifesciences reported revenue of $6.1B for the fiscal year ended 31 Dec 2025. Net income over the same period was $1.1B.

Figure Reported Period
Revenue $6.1B 31 Dec 2025 fiscal year
Net income $1.1B 31 Dec 2025 fiscal year
Diluted EPS $1.83 31 Dec 2025 fiscal year
Total assets $13.9B 30 Jun 2026 at period end
Total equity $10.6B 30 Jun 2026 at period end

Edwards Lifesciences (EW) earnings

SEC EDGAR

Edwards Lifesciences last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.42; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.42 $1.74B
31 Mar 2026 Q1 2026 $0.66 $1.65B
31 Dec 2025 FY 2025 $1.83 $6.07B
30 Sep 2025 Q3 2025 $0.50 $1.55B
30 Jun 2025 Q2 2025 $0.56 $1.53B
31 Mar 2025 Q1 2025 $0.61 $1.41B
31 Dec 2024 FY 2024 $0.65 $1.39B
30 Sep 2024 Q3 2024 $5.13 $1.35B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Edwards Lifesciences (EW) institutional holders (13F)

SEC Form 13F SEC EDGAR

11 of the 45 institutional funds we track reported a Edwards Lifesciences position for the quarter ended 30 Jun 2026 — a combined $1.3B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Citadel Advisors Added +670.3% shares 3,997,925 $361.7M
Millennium Management Added +99.5% shares 3,584,795 $324.3M
Point72 Asset Management Held (±25%) −2.9% shares 1,774,120 $160.5M
Two Sigma Investments Added +44.7% shares 1,521,899 $137.7M
AQR Capital Management Trimmed −25.6% shares 1,465,185 $132.2M
Man Group Held (±25%) −18.5% shares 935,186 $84.6M
Balyasny Asset Management Added +4,462.9% shares 456,202 $41.3M
Marshall Wace Trimmed −82.8% shares 344,361 $31.2M
Bridgewater Associates Added +60.1% shares 275,279 $24.9M
Fisher Asset Management Trimmed −33.6% shares 87,769 $7.9M

Showing the 10 largest of 11 reported positions. The figures above count all of them.

Edwards Lifesciences (EW) fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 74 shares of Edwards Lifesciences failed to deliver (about $7K).

Settlement date Shares failed Notional % of shares out
30 Sep 2026 74 $7K <0.001%
24 Sep 2026 32 $3K <0.001%
21 Sep 2026 4,800 $424K 0.001%
09 Sep 2026 54 $5K <0.001%
08 Sep 2026 94 $8K <0.001%

Congressional trades in Edwards Lifesciences (EW)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Edwards Lifesciences is a sale by Josh Gottheimer (house, NJ), dated 19 Nov 2025.

Date Member Type Amount
19 Nov 2025 filed 29 Dec 2025 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
21 Apr 2025 filed 12 May 2025 Bruce Westerman house · Republican–AR Sale $1K–$15K
08 Apr 2025 filed 08 May 2025 Robert P. Bresnahan, Jr. house · Republican–PA Purchase $1K–$15K
03 Mar 2025 filed 16 Apr 2025 Bruce Westerman house · Republican–AR Purchase $1K–$15K
11 Apr 2024 filed 14 Jun 2024 Mike Kelly house · Republican–PA Sale $1K–$15K
11 Dec 2023 filed 07 Jan 2024 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
04 Dec 2023 filed 15 Dec 2023 John R. Curtis senate · Republican–UT Sale $1K–$15K
21 Jun 2023 filed 07 Aug 2023 John R. Curtis senate · Republican–UT Purchase $1K–$15K

Edwards Lifesciences (EW): frequently asked questions

From live data

Have Edwards Lifesciences insiders bought or sold shares recently?

In the 90 days to 21 Oct 2026, Edwards Lifesciences insiders reported 10 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 22 Feb 2026, show no open-market purchase. A further 10 filings were grants, awards, gifts or exercises rather than open-market trades.

How many institutions hold Edwards Lifesciences?

11 of the 45 institutional funds we track reported a Edwards Lifesciences position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Edwards Lifesciences had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Edwards Lifesciences is dated 30 Sep 2026, when 74 shares failed to deliver.

When did Edwards Lifesciences last report earnings?

Edwards Lifesciences last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.42; no next date is announced in SEC filings yet.

What exchange is Edwards Lifesciences listed on?

Edwards Lifesciences trades on NYSE under the ticker EW.

What is Reddit saying about Edwards Lifesciences?

Edwards Lifesciences was mentioned 2 times in the last 7 days across the finance subreddits we track, and 11 times over the trailing 30 days. Of 11 classified mentions, 64% read bullish, 18% bearish and 18% neutral. Crowd sentiment is a social signal, not investment advice.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SEC EDGARValuation computed from SEC EDGAR filings